XML 61 R49.htm IDEA: XBRL DOCUMENT v3.22.1
Revenue Recognition - Schedule of Revenues from Major Customers (Detail) - Product Concentration Risk [Member] - Revenue Benchmark [Member]
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Largest Customer | HEPLISAV-B    
Concentration Risk [Line Items]    
Percentage of product revenue 25.00% 28.00%
Second Largest Customer | HEPLISAV-B    
Concentration Risk [Line Items]    
Percentage of product revenue 20.00% 26.00%
Third Largest Customer | HEPLISAV-B    
Concentration Risk [Line Items]    
Percentage of product revenue 16.00% 21.00%
Largest Collaboration Partner | CpG 1018    
Concentration Risk [Line Items]    
Percentage of product revenue 74.00% 87.00%
Second Largest Collaboration Partner | CpG 1018    
Concentration Risk [Line Items]    
Percentage of product revenue 24.00% 9.00%
Third largest collaboration partner | CpG 1018    
Concentration Risk [Line Items]    
Percentage of product revenue 2.00% 2.00%